Evaxion Biotech A/S ADR [NASDAQ: EVAX] price surged by 36.25 percent to reach at $0.87. The one-year EVAX stock forecast points to a potential upside of 89.76. The average equity rating for EVAX stock is currently 1.00, trading closer to a bullish pattern in the
Evaxion Biotech A/S ADR [NASDAQ: EVAX] price surged by 52.94 percent to reach at $1.26. The one-year EVAX stock forecast points to a potential upside of 91.25. The average equity rating for EVAX stock is currently 1.00, trading closer to a bullish pattern in the
Evaxion Biotech’s (Nasdaq: EVAX) shares surged 39.87% to $2.14 in premarket trading. Despite a minor dip of -0.65% to $1.53 in the previous session, the clinical-stage biotech firm focusing on AI-driven immunotherapies experienced a boost after sharing clinical data. Which Data Has EVAX Presented? Evaxion
Copyright © 2024, Powered by Smart TechOne
